[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK1231915T3 - Anvendelse af pleuromutilinderivater til transdermal behandling af bakterielle sygdomme - Google Patents

Anvendelse af pleuromutilinderivater til transdermal behandling af bakterielle sygdomme

Info

Publication number
DK1231915T3
DK1231915T3 DK00993165T DK00993165T DK1231915T3 DK 1231915 T3 DK1231915 T3 DK 1231915T3 DK 00993165 T DK00993165 T DK 00993165T DK 00993165 T DK00993165 T DK 00993165T DK 1231915 T3 DK1231915 T3 DK 1231915T3
Authority
DK
Denmark
Prior art keywords
bacterial diseases
transdermal treatment
pleuromutiline
derivatives
pleuromutiline derivatives
Prior art date
Application number
DK00993165T
Other languages
English (en)
Inventor
Erich Zeisl
Paul Howard Ripley
Stefan Horkovics-Kovats
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8239432&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1231915(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK1231915T3 publication Critical patent/DK1231915T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK00993165T 1999-11-22 2000-11-20 Anvendelse af pleuromutilinderivater til transdermal behandling af bakterielle sygdomme DK1231915T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99123095 1999-11-22
PCT/EP2000/011519 WO2001037828A1 (en) 1999-11-22 2000-11-20 Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases

Publications (1)

Publication Number Publication Date
DK1231915T3 true DK1231915T3 (da) 2005-05-02

Family

ID=8239432

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00993165T DK1231915T3 (da) 1999-11-22 2000-11-20 Anvendelse af pleuromutilinderivater til transdermal behandling af bakterielle sygdomme

Country Status (22)

Country Link
US (1) US6852756B1 (da)
EP (1) EP1231915B1 (da)
JP (1) JP3892298B2 (da)
KR (1) KR100529660B1 (da)
CN (1) CN100344281C (da)
AR (1) AR026523A1 (da)
AT (1) ATE289196T1 (da)
AU (1) AU764451B2 (da)
BR (1) BR0015722A (da)
CA (1) CA2386685C (da)
CO (1) CO5261531A1 (da)
DE (1) DE60018200T2 (da)
DK (1) DK1231915T3 (da)
ES (1) ES2237495T3 (da)
HK (1) HK1052643B (da)
MX (1) MXPA02005149A (da)
NZ (1) NZ518348A (da)
PT (1) PT1231915E (da)
RU (1) RU2264812C2 (da)
TW (1) TWI260220B (da)
WO (1) WO2001037828A1 (da)
ZA (1) ZA200203901B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60214376T2 (de) * 2001-06-15 2007-08-30 Innovent Technology Ltd., Turriff Zusammensetzung zur behandlung von huf- und klauenerkrankungen
CO5390081A1 (es) 2001-11-28 2004-04-30 Novartis Ag Compuestos organicos
ATE450535T1 (de) * 2003-09-03 2009-12-15 Glaxo Group Ltd Neues verfahren zur herstellung von pleuromutilinderivaten
GB0504314D0 (en) 2005-03-02 2005-04-06 Glaxo Group Ltd Novel polymorph
EP1808431A1 (en) * 2006-01-16 2007-07-18 Nabriva Therapeutics Forschungs GmbH Mutilin derivatives and their use as pharmaceutical
CN102415989A (zh) * 2011-09-30 2012-04-18 上海恒丰强动物药业有限公司 盐酸沃尼妙林溶液剂及其制备方法
GB2571235B (en) * 2016-11-09 2021-05-19 Provita Eurotech Ltd Antimicrobial formulations for the treatment of veterinary hoof infections
GB201715122D0 (en) * 2017-09-19 2017-11-01 Omnipharm Dev Ltd Topical anti-infective formulation
KR102098289B1 (ko) * 2018-04-11 2020-04-07 경북대학교 산학협력단 발네물린을 유효성분으로 함유하는 골 질환 예방 또는 치료용 조성물
CN109431980A (zh) * 2018-12-27 2019-03-08 山东齐发药业有限公司 一种用于治疗动物皮肤细菌感染的羟啶妙林软膏剂及其制备方法
CN114366732B (zh) * 2022-02-23 2023-08-18 中国医学科学院皮肤病医院(中国医学科学院皮肤病研究所) 泰妙菌素在制备用于治疗银屑病的药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT301752B (de) * 1969-07-21 1972-09-25 Biochemie Gmbh Verfahren zur Herstellung neuer Pleuromutilin-Derivate
DE2614841A1 (de) 1976-04-06 1977-10-20 Bayer Ag Neue pour-on-formulierungen von anthelmintika
EP0153277B1 (de) * 1984-02-17 1987-08-26 Sandoz Ag Neue Pleuromutilinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung
AT400674B (de) * 1991-07-24 1996-02-26 Biochemie Gmbh Pharmazeutische pleuromutilin-zubereitung
GB9614017D0 (en) * 1996-07-04 1996-09-04 Biochemie Gmbh Organic compounds
GB9807503D0 (en) * 1998-04-07 1998-06-10 Smithkline Beecham Plc Use

Also Published As

Publication number Publication date
JP2003514856A (ja) 2003-04-22
CO5261531A1 (es) 2003-03-31
MXPA02005149A (es) 2002-11-07
KR100529660B1 (ko) 2005-11-21
HK1052643B (zh) 2008-03-14
ES2237495T3 (es) 2005-08-01
WO2001037828A1 (en) 2001-05-31
KR20020053876A (ko) 2002-07-05
AU764451B2 (en) 2003-08-21
AR026523A1 (es) 2003-02-12
ATE289196T1 (de) 2005-03-15
EP1231915A1 (en) 2002-08-21
CA2386685C (en) 2009-05-19
BR0015722A (pt) 2002-07-23
CN1391472A (zh) 2003-01-15
RU2002116252A (ru) 2004-01-20
JP3892298B2 (ja) 2007-03-14
HK1052643A1 (en) 2003-09-26
AU2836501A (en) 2001-06-04
RU2264812C2 (ru) 2005-11-27
NZ518348A (en) 2003-11-28
TWI260220B (en) 2006-08-21
EP1231915B1 (en) 2005-02-16
US6852756B1 (en) 2005-02-08
CA2386685A1 (en) 2001-05-31
CN100344281C (zh) 2007-10-24
ZA200203901B (en) 2003-09-23
DE60018200D1 (de) 2005-03-24
DE60018200T2 (de) 2006-01-12
PT1231915E (pt) 2005-07-29

Similar Documents

Publication Publication Date Title
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
NO20014960L (no) Nye fremgangsmåter for behandling
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
DK1803718T3 (da) 4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter
DE60105295D1 (de) Chinazolinderivate zur behandlung von tumoren
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DK1282616T3 (da) Hydroxyphenylpiperidin-4-ylidenmethylbenzamidderivater til behandling af smerter
NO20014950D0 (no) Nye behandlingsmetoder
DK1231915T3 (da) Anvendelse af pleuromutilinderivater til transdermal behandling af bakterielle sygdomme
NO20024777L (no) Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte
NO20024776D0 (no) Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte
EE200100623A (et) Melatoniini terapeutiline kasutamine
NO20041378L (no) [[2-(Amino-3,4-diokso-1-cyklobuten-1-yl)amino]alkyl]-syrederivater for behandling av smerte
ATE307805T1 (de) Imidazolonderivate zur behandlung viraler krankheiten
IS6020A (is) S-nítrósóþíól til meðferðar við blóðrásartruflunum
DE60025705D1 (de) Antikonvulsive derivate zur behandlung von essentiellem tremor
ATE261965T1 (de) Bispidin-derivate zur behandlung von herzarrhythmien
ATE259809T1 (de) Bispidin-derivate zur behandlung von herzarrhythmien
DK1286986T3 (da) Quinolinylpiperidin-4-ylidenmethylbenzamidderivater til behandling af smerte
UA33595A (uk) Спосіб лікування простої шизофренії
UA33556A (uk) Спосіб лікування хворих шизофренією
UA33583A (uk) Спосіб терапії простої шизофренії
UA36394A (uk) Спосіб лікування обтураційної жовтяниці
DK1077931T3 (da) Benzamidderivater til behandling af sygdomme formidlet af cytokiner